Blog

Home/News/Fujifilm shares tumble after report Avigan not showing apparent efficacy in coronavirus treatment

Fujifilm shares tumble after report Avigan not showing apparent efficacy in coronavirus treatment

Shares of Fujifilm Holdings Corp tumbled more than 4% in early trade on Wednesday after a report its anti-flu drug Avigan was not showing apparent efficacy in coronavirus treatment in clinical trials so far.

    

Written by

Peter Zirbes, ESQ. A Full Service Law Office 718 544 6300